Patents by Inventor Steve Kanzer

Steve Kanzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200323781
    Abstract: The present invention relates to, in part, methods and compositions for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel Syndrome (IBS). Particularly, modified-release formulations comprising at least one antimethanogenic statin are provided which release the antimethanogenic statin in the intestines.
    Type: Application
    Filed: April 27, 2020
    Publication date: October 15, 2020
    Applicants: Cedars-Sinai Medical Center, Synthetic Biologics, Inc.
    Inventors: Mark Pimentel, Ruchi Mathur, Steve Kanzer, Vince Wacher
  • Patent number: 10668159
    Abstract: The present invention relates to, in part, methods and compositions for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel Syndrome (IBS). Particularly, modified-release formulations comprising at least one antimethanogenic statin are provided which release the antimethanogenic statin in the intestines.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: June 2, 2020
    Assignee: Cedars-Sinai Medical Center
    Inventors: Mark Pimentel, Ruchi Mathur, Steve Kanzer, Vince Wacher
  • Publication number: 20190328885
    Abstract: The present invention relates to, in part, methods and compositions for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel Syndrome (IBS). Particularly, modified-release formulations comprising at least one antimethanogenic statin are provided which release the antimethanogenic statin in the intestines.
    Type: Application
    Filed: May 7, 2019
    Publication date: October 31, 2019
    Applicants: Cedars-Sinai Medical Center, Synthetic Biologics, Inc.
    Inventors: Mark Pimentel, Ruchi Mathur, Steve Kanzer, Vince Wacher
  • Patent number: 10328151
    Abstract: The present invention relates to, in part, methods and compositions for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel Syndrome (IBS). Particularly, modified-release formulations comprising at least one antimethanogenic statin are provided which release the antimethanogenic statin in the intestines.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: June 25, 2019
    Assignee: Cedars-Sinai Medical Center
    Inventors: Mark Pimentel, Ruchi Mathur, Steve Kanzer, Vince Wacher
  • Publication number: 20180289816
    Abstract: The present invention relates to, in part, methods and compositions for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel Syndrome (IBS). Particularly, modified-release formulations comprising at least one antimethanogenic statin are provided which release the antimethanogenic statin in the intestines.
    Type: Application
    Filed: March 29, 2018
    Publication date: October 11, 2018
    Applicants: Cedars-Sinai Medical Center, Synthetic Biologics, Inc.
    Inventors: Mark Pimentel, Ruchi Mathur, Steve Kanzer, Vince Wacher
  • Patent number: 9956292
    Abstract: The present invention relates to, in part, methods and compositions for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel Syndrome (IBS). Particularly, modified-release formulations comprising at least one antimethanogenic statin are provided which release the antimethanogenic statin in the intestines.
    Type: Grant
    Filed: August 13, 2015
    Date of Patent: May 1, 2018
    Assignees: Cedars-Sinai Medical Center, Synthetic Biologics, Inc.
    Inventors: Mark Pimentel, Ruchi Mathur, Steve Kanzer, Vince Wacher
  • Publication number: 20160045604
    Abstract: The present invention relates to, in part, methods and compositions for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel Syndrome (IBS). Particularly, modified-release formulations comprising at least one antimethanogenic statin are provided which release the antimethanogenic statin in the intestines.
    Type: Application
    Filed: August 13, 2015
    Publication date: February 18, 2016
    Applicants: Synthetic Biologics, Inc., Cedars-Sinai Medical Center
    Inventors: Mark Pimentel, Ruchi Mathur, Steve Kanzer, Vince Wacher
  • Publication number: 20070209950
    Abstract: A detection method or a method for a point of care diagnostic assay which comprises detecting non-covalently bound copper (free copper) concentrations in a fluid.
    Type: Application
    Filed: February 12, 2007
    Publication date: September 13, 2007
    Inventors: John ALTHAUS, Steve KANZER
  • Publication number: 20070207191
    Abstract: Compositions and methods are provided that comprise improved means to achieve and maintain a targeted level of copper status in persons in order to treat and prevent copper associated diseases.
    Type: Application
    Filed: May 7, 2007
    Publication date: September 6, 2007
    Inventors: Steve KANZER, George Brewer, Nicholas Stergis, John Althaus, Charles Bisgaier
  • Publication number: 20070201303
    Abstract: A method and apparatus for making non-staining coffee or tea includes an ion exchanger for removing heavy metals from the brewed coffee or tea or from the water used to brew the coffee or tea.
    Type: Application
    Filed: January 23, 2007
    Publication date: August 30, 2007
    Inventors: Steve KANZER, John Althaus
  • Publication number: 20070199567
    Abstract: A filtering face mask that comprises: (a) a mask body; and (b) at least one diagnostic device for identifying whether the wearer of the mask is infected with a contagious disease.
    Type: Application
    Filed: January 25, 2007
    Publication date: August 30, 2007
    Inventor: Steve KANZER
  • Publication number: 20060252735
    Abstract: A method for reducing mortality associated with GVHD by treating the patent with an oral BDP regimen that involves co-administration of: 1) a high dose of prednisone (about 1-2 mg/kg/day) for about 10 days, which is then tapered rapidly over the following 7 days to a physiological replacement dose of about 0.0625 mg/kg/day for the remainder of the treatment, and 2) about 4-12 mg oral BDP q.i.d. for about 50 days, where the BDP is administered in both immediate release and enteric coated preparations. Another method is for treating leukemia by performing hematopoietic cell transplantation followed by said regimen.
    Type: Application
    Filed: December 30, 2005
    Publication date: November 9, 2006
    Applicant: DOR BioPharma, Inc.
    Inventors: George McDonald, Nicholas Stergiopoulos, Steve Kanzer
  • Publication number: 20030046816
    Abstract: A shaving razor includes a razor housing comprising a heat sink element for holding thermal energy and releasing it in a controlled, sustained fashion to heat the shaving surface ahead of the razor blade.
    Type: Application
    Filed: March 1, 2002
    Publication date: March 13, 2003
    Inventor: Steve Kanzer